Effects of add-on Celecoxib treatment on patients with schizophrenia spectrum disorders and inflammatory cytokine profile trial (TargetFlame): study design and methodology of a multicentre randomized, placebo-controlled trial

<p>Neuroinflammation has been proposed to impact symptomatology in patients with schizophrenia spectrum disorders. While previous studies have shown equivocal effects of treatments with add-on anti-inflammatory drugs such as Aspirin, <i>N</i>-acetylcysteine and Celecoxib, none have...

Full description

Bibliographic Details
Main Authors: Strube, W, Aksar, A, Bauer, I, Barbosa, S, Benros, M, Blankenstein, C, Campana, M, Davidovic, L, Glaichenhaus, N, Falkai, P, Görlitz, T, Hansbauer, M, Heilig, D, Khalfallah, O, Leboyer, M, Martinuzzi, E, Mayer, S, Moussiopoulou, J, Papazova, I, Perić, N, Wagner, E, Schneider-Axmann, T, Simon, J, Hasan, A
Format: Journal article
Language:English
Published: Springer 2022

Similar Items